Johnson & Johnson has completed the acquisition of Merck’s share in Consumer Pharmaceuticals, originally a joint venture between the two companies, for a fee of $175m.

Johnson & Johnson will assume full ownership of the company, which is to be renamed as McNeil Consumer Pharmaceuticals.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Merck said that it had decided to sell its stake in the venture in order to focus fully on long-term growth prospects of its wholly owned consumer products division.

As per the agreement, ownership of a manufacturing facility in Pennsylvania, US, will transfer to McNeil.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now